2. Academic Validation
  3. Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis

Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis

  • Oncogene. 2020 Sep;39(37):5950-5963. doi: 10.1038/s41388-020-01413-w.
Chun-Jung Ko  # 1 2,  Ting-Wei Hsu  # 1,  Shang-Ru Wu 1,  Shao-Wei Lan 1,  Ting-Feng Hsiao 3 4,  Hsin-Ying Lin 1,  Hsin-Hsien Lin 1,  Hsin-Fang Tu 1,  Cheng-Fan Lee 1,  Cheng-Chung Huang 1,  Mei-Ju May Chen 5,  Pei-Wen Hsiao 6,  Hsiang-Po Huang 7,  Ming-Shyue Lee 8
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • 2 Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • 3 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • 4 Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • 5 Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • 6 Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
  • 7 Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • 8 Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan. mslee2006@ntu.edu.tw.
  • # Contributed equally.
PMID: 32778768 DOI: 10.1038/s41388-020-01413-w
Abstract

TMPRSS2 is an important membrane-anchored serine Protease involved in human prostate Cancer progression and metastasis. A serine Protease physiologically often comes together with a cognate inhibitor for execution of proteolytically biologic function; however, TMPRSS2's cognate inhibitor is still elusive. To identify the cognate inhibitor of TMPRSS2, in this study, we applied co-immunoprecipitation and LC/MS/MS analysis and isolated hepatocyte growth factor activator inhibitors (HAIs) to be potential inhibitor candidates for TMPRSS2. Moreover, the recombinant HAI-2 proteins exhibited a better inhibitory effect on TMPRSS2 proteolytic activity than HAI-1, and recombinant HAI-2 proteins had a high affinity to form a complex with TMPRSS2. The immunofluorescence images further showed that TMPRSS2 was co-localized to HAI-2. Both KD1 and KD2 domain of HAI-2 showed comparable inhibitory effects on TMPRSS2 proteolytic activity. In addition, HAI-2 overexpression could suppress the induction effect of TMPRSS2 on pro-HGF activation, extracellular matrix degradation and prostate Cancer cell invasion. We further determined that the expression levels of TMPRSS2 were inversely correlated with HAI-2 levels during prostate Cancer progression. In orthotopic xenograft animal model, TMPRSS2 overexpression promoted prostate Cancer metastasis, and HAI-2 overexpression efficiently blocked TMPRSS2-induced metastasis. In summary, the results together indicate that HAI-2 can function as a cognate inhibitor for TMPRSS2 in human prostate Cancer cells and may serve as a potential factor to suppress TMPRSS2-mediated malignancy.

Figures
Products